Europe & the Storm Ahead - Research Report on Johnson & Johnson and Pfizer Inc.
(firmenpresse) - MACAU -- (Marketwire) -- 08/15/11 -- Today, announced its research report highlighting Johnson & Johnson (NYSE: JNJ) and Pfizer Inc. (NYSE: PFE). Full content and research is available at .
Continued confidence in long-term U.S. debt is defying S&P's recent downgrade. Treasury yields fell to their lowest level since January 1, 2011 as the market moved to "safe investments" weary of the storm clouds ahead. Winds can change however, as a last-minute move to save the U.S. from a historic default on its debt obligations. Attentions are now turned to the situation in Europe, with the health of the Euro in the balance; bankers are looking to prevent defaults on Italian and Spanish debt.
As a result of recent credit adjustments, opportunity is being marked for investors to take advantage of equities with high-margin and specialty products. Market-wise investors are carefully watching for value within equities boasting established pipelines and excellent growth prospects. As part of this process, the following companies have been introduced with initial research reports available online.
Equity Markets has reviewed Johnson & Johnson as a company which is engaged in the research and development, manufacture and sale of a range of products in the health care field. It has more than 250 operating companies conducting business worldwide. The full research report on Johnson & Johnson (NYSE: JNJ) is available here: .
Equity Markets is covering Pfizer Inc. as a research-based, global biopharmaceutical company. The Company operates in two segments: Biopharmaceutical and Diversified. Biopharmaceutical includes the Primary Care, Specialty Care, Established Products, Emerging Markets and Oncology customer-focused units. The full research report on Pfizer Inc. (NYSE: PFE) is available here: .
About Equity Markets
Our mission at Equity Markets is to be the best source of content and research, while educating, enlightening and informing investors. Equity Markets combines street smart analysts and professional market researchers to provide investors with detailed company profiles and market coverage.
Contact:
Samuel Littman
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 15.08.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 1030465
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
MACAU
Phone:
Kategorie:
Commercial & Investment Banking
Anmerkungen:
Diese Pressemitteilung wurde bisher 87 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Europe & the Storm Ahead - Research Report on Johnson & Johnson and Pfizer Inc.
"
steht unter der journalistisch-redaktionellen Verantwortung von
Equity Markets Inc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
